Mulligan et al., 1992, "Lung Injury After Deposition of IgA Immune Complexes," J. Immunol. 148:3086-3092. |
Mulligan et al., 1992, "Protective Effects of Soluble CR1 in Complement and Neutrophil-Mediated Tissue Injury", J. Immunol 148:1479-1485. |
Pruitt et al., 1991, "The Effect of Soluble Complement Receptor Type 1 on Hyperacute Xenograft Rejection," Transplantation 52:868-873. |
Pruitt and Bolinger, 1991, "The Effects of Soluble Complement Receptor Type 1 on Hyperacute Allograft Rejection," J. Surg. Res. 50:350-355. |
Yeh et al., 1991, "Recombinant Soluble Human Complement Receptor Type 1 Inhibits Inflammation In The Reversed Passive Arthus Reaction in Rats," J. Immunol. 146:250-256. |
Weisman et al., 1990, "Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post Ischemic Myocardial Inflammation and Necrosis," Science 249:146-151. |
Yoon and Fearon, 1985, "Chacterization of a Soluble Form of the C3b/C4b receptor (CR1) In Human Plasma," J. Immunol. 134:3332-3338. |
Krych et al., 1989, "A Secreted Small Form of Human Complement C3b/C4b Receptor (CR1) that Binds to C4b But Not C3b," F.A.S.E.B. J. 3:A368. |
Klickstein et al., 1988, "Identification of Distinct C3b and C4b Recognition Sites in the Human C3b/C4b Receptor (CR1, CD35) By Deletion Mutagenesis," J. Exp. Med. 168:1699-1717. |
Hourcade et al., 1988, Identification of an Alternative Polyadenylation Site in the Human C3b/C4b Receptor (Complement Receptor Type 1) Transcriptional Unit and Prediction of a Secreted Form of Complement Receptor Type 1, J. Exp. Med. 168:1255-1270. |
Klickstein et al., 1987, "Human C3b/C4b Receptor (CR1)," J. Exp. Med. 165:1095-1112. |
Wong et al., 1985, "Rapid Purification of the Human C3b/C4b Receptor (CR1) by Monoclonal Antibody Affinity Chromatography," J. Immunol. Methods 82:303-313. |
Lublin et al., 1986, "Influence of Glycosylation on Allelic and Cell-specific Mr. Variation, Receptor Processing, and Ligand Binding of the Human Complement C3b/C4b Receptor," J. Biol. Chem. 261:5736. |
Sim, 1985, "Large-Scale Isolation of Complement Receptor Type 1 (CR1) From Human Erythrocytes," Biochem J. 232:883-889. |
Skubitz and Snook, 1987, "Monoclonal Antibodies That Recognize Lacto-N-Fucopentaose III (CD 15) React With the Adhesion-Promoting Glycoprotein Family (LFA-1/HMAC-1/GP 150,95) and CR1 On Human Neutrophils," J. Immunol. 139:1631-1639. |
West, 1986, "Current Ideas on the Significance of Protein Glycosylation," Mol. Cell. Biochem. 72:3-20. |
Goochee and Monica, 1990, "Environmental Effects on Protein Glycosylation," Bio/Technology 8:421-427. |
Takenchi et al., 1988, "Comparative Study of the Asparagine-linked Sugar Chains of Human Erythroproteins Purified from Urine and the Culture Medium of Recombinant Chinese Hamster Ovary Cells", J. Biol. Chem. 263:3657-3663. |
Parekh et al., 1989, "N-glycosylation and the production of recombinant glycoproteins", Trends in Biotechnol. 7: 117-122. |
Makrides et al. 1992, "Cell Surface Expression of the C3b/C4b Receptor (CR1) Protects Chinese Hamster Ovary Cells from Lysis by Human Complement," J. Biol. Chem. 267:24754-24761. |
Stanley et al., 1988, "The LEC11 Chinese Hamster Ovary Mutant Synthesized N-Linked Carbohydrates Containing Sialylated, Fucosylated Lactosamine Units," J. Biol. Chem. 263:11374-11381. |
Paulson, 1989, "Glycoproteins: what are the sugar chains for?" Trends In Biochem. Sci. 14:272-276. |
Goochee et al., 1991, "The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and Their Effect on Glycoprotein Properties," Biotechnology 9:1347-1355. |
Kobata, Akira, 1992, "Structures and Functions of the Sugar Chains of Glycoproteins," Eur. J. Biochem. 209:483-501. |